Contact Person
    Sophie Labrosse

    Project Manager
    Email: sol@mva.org
    Phone: (M) +45 24 60 00 46
    Linkedin

    MVA Oncology Network meeting

     

    Welcome to the MVA Oncology Network and our 9th meeting!
    The future of oncology – treatments in multiple combinations.

    Combination therapies are upcoming within oncology R&D, but what is the right strategy for their development in the early stages? At this meeting we will look into the optimal design of early clinical trials, the challenges of value and pricing-setting of combination treatments, and get more insight in the patient experience.  

    Medicon Valley Alliance, together with one of our members – AbbVie – welcomes you to the MVA Oncology Network and our 9th meeting where we will discuss the future of oncology – treatments in multiple combinations. The meeting format will include presentations and a panel discussion, so all can actively engage.

    Date:

    23 March, 2020

    Time:

    17:00 – 20:00

    Host:

    AbbVie

    Venue:

    Medicon Valley Alliance, Arne Jacobsens Allé 15, DK-2300 Copenhagen S, Danmark

    Cost:

    Free of charge for MVA members

    Deadline: 

    18 March, 2020

    Sign up

    The network
    MVA Oncology Network is a professional and social network for professors, PIs and corporate level executives from the regional oncology eco-system. The network focuses on best practice, experience and current challenges for public-private collaboration and the commercialization of oncology related R&D in the Medicon Valley region.

    Joining the network is free of charge and is limited to Medicon Valley Alliance members only. However, non-member organizations and companies are welcome to attend one network event to evaluate if joining the network is relevant. If so, becoming a member of Medicon Valley Alliance will automatically allow you to join the oncology network.

    Program

    Moderator: Linn Mandahl, General Manager, AbbVie Scandinavia

    17:00-17:30 

    Registration, networking and a bite to eat – meet the fellow participants

    17:30-17:35 

    Welcome 
    Linn Mandahl, General Manager, AbbVie Scandinavia

    17:35-17:40 

    Sponsor Pitch
    Jens Viktor Nørgaard, Partner, European Patent Attorney, HØIBERG

    17:40-18:20

    “Who are we?” 4 x 10 minute corporate/academic presentations
    Pitches from MVA Oncology Network organizations

    Albin Jakobsson, CTO, Cellevate

    Liselotte Nilsson, Head of Marketing, Phase Holographic, Phase Holographic

    Mikkel Pedersen, SVP and Acting Chief Scientific Officer, Symphogen 

    Anne-Sofie Andersson-Ward, Clinical Partnerships Manager Nordics, Kaiku Health

    18:20-18:50

    The future of oncology: treatments in multiple combinations.

    • Optimal design of early trials 

    • The challenges of defining value of combination treatments     

    • Patient perspective: what parameters to remember to include in early trials

    18:50-19:20

    Panel discussion

    Moderator: Linn Mandahl, General Manager, AbbVie Scandinavia

    19:20

    Concluding remarks

    19:30-20:00

    Networking and refreshments

      Host
     

     

    Sponsor 

     

     

     

    MVA Oncology Network is managed by

     

    In collaboration with